Beskrywing

Metabolomics is an analytical profiling technique for measuring and comparing large numbers of metabolites present in biological samples. Combining high-throughput analytical chemistry and multivariate data analysis, metabolomics offers a window on metabolic mechanisms. The global metabolomics market is poised to grow by US$ 12.1 miljard tydens 2022-2028, vorder teen 'n CAGR van 11.8% gedurende die voorspellingsperiode, volgens die data- en ontledingsmaatskappy StrategyHelix.

Die verslag verskaf up-to-date markgrootte data vir tydperk 2018-2021 en voorspel tot 2028 covering key market aspects like sales value for metabolomics. The global metabolomics market is segmented on the basis of product, indication, aansoek, en streek. Per produk, the global metabolomics market has been segmented into assays, bioinformatics, detection techniques, separation techniques. The separation techniques segment was the largest contributor to the global metabolomics market in 2021. Based upon indication, the global metabolomics market is categorized into cancer, cardiovascular disorders, inborn errors of metabolism, neurological disorders, ander. Volgens die navorsing, the cancer segment had the largest share in the global metabolomics market. On the basis of application, the global metabolomics market has been segmented into biomarker discovery, drug discovery, functional genomics, nutrigenomics, toxicology testing, ander. The biomarker discovery segment held the largest revenue share in 2021. Geografies, the global metabolomics market is segmented into Asia Pacific, Europa, Noord-Amerika, MEA (Midde-Ooste en Afrika), Latyns-Amerika. Globally, North America made up the largest share of the metabolomics market.

The separation techniques market is further segmented into capillary electrophoresis, gas chromatography, and liquid chromatography (high-performance liquid chromatography and ultra-performance liquid chromatography). The liquid chromatography (high-performance liquid chromatography and ultra-performance liquid chromatography) segment is estimated to account for the largest share of the global metabolomics market. Verder, the detection techniques market has been categorized into mass spectrometry, multivariate analysis, and spectroscopy (NMR and FTIR). The mass spectrometry segment held the largest share of the global metabolomics market in 2021 and is anticipated to hold its share during the forecast period.

The global metabolomics market is highly competitive. The report also includes the profiles of leading companies such as Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, LECO Corporation, Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation.

Die verslag is 'n waardevolle hulpbron vir maatskappye en organisasies wat in hierdie bedryf aktief is. It provides a cohesive picture of the metabolomics market to help drive informed decision making for industry executives, beleidmakers, akademies, en ontleders.

Verslag Omvang

Produk: assays, bioinformatics, detection techniques, separation techniques
Indication: cancer, cardiovascular disorders, inborn errors of metabolism, neurological disorders, ander
Toepassing: biomarker discovery, drug discovery, functional genomics, nutrigenomics, toxicology testing, ander
Streek: Asiatiese Stille-Oseaan, Europa, Noord-Amerika, MEA (Midde-Ooste en Afrika), Latyns-Amerika
Jare oorweeg: hierdie verslag dek die tydperk 2018 aan 2028

Sleutelvoordele vir belanghebbendes

– Get a comprehensive picture of the global metabolomics market
– Bepaal groeisektore en -neigings vir belegging

INHOUDSOPGAWE

Deel 1. Inleiding
– Omvang van die studie
– Studietydperk
– Geografiese omvang
– Navorsingsmetodologie
Deel 2. Metabolomics market overview
Deel 3. Market breakdown by product
– Assays
– Bioinformatics
– Detection techniques
– Separation techniques
Deel 4. Market breakdown by indication
– Cancer
– Cardiovascular disorders
– Inborn errors of metabolism
– Neurological disorders
– Ander
Deel 5. Markverdeling volgens toepassing
– Biomarker discovery
– Drug discovery
– Functional genomics
– Nutrigenomics
– Toxicology testing
– Ander
Deel 6. Market breakdown by region
– Asiatiese Stille-Oseaan
– Europa
– Noord-Amerika
– MEA (Midde-Ooste en Afrika)
– Latyns-Amerika
Deel 7. Sleutel maatskappye
– Agilent Technologies Inc.
– Bio-Rad Laboratories Inc.
– Bruker Corporation
– Danaher Corporation
– LECO Corporation
– Metabolon Inc.
– Shimadzu Corporation
– Thermo Fisher Scientific Inc.
– Waters Corporation
Oor StrategyHelix
Vrywaring